Healthcare costs are expected to rise by nearly 8% in 2025 ... In addition, more people are using GLP-1 weight loss drugs, including Ozempic, Wegovy, Zepbound and Mounjaro, to treat diabetes, obesity ...

The largest healthcare stocks by market capitalization are undergoing significant sell-offs. UnitedHealth is still a large ...

Dr Bryan Betty joined Jack Tame to discuss Wegovy – what it is, how you use it, the side effects, and why people are seeking medical treatment for their weight. A once-weekly injection for weight loss ...

The digital health market is welcoming new IPOs for the first time in years. Bankers and investors think these 9 startups ...

The market for generic GLP-1 weight loss drugs in Canada is set to open up, and Hims & Hers is ready to jump in.  | Novo ...

The following is a special feature from CivicScience CEO and Founder John Dick. Learn how you can turn insights like these ...

The preventative healthcare measures recommended in the Scotland’s Population Health Framework 2025-2035 plan have been ...

Sustainability awareness remains strong in the Middle East, with 75% of respondents expressing concern about climate change.

The Secretary of Health Services wants every American to use a wearable device in the next four years. Experts say it's a ...

He contrasted the expense with Ozempic — a diabetes and weight-loss medication that costs over $1,000 per month — and argued that wearables could be a more cost-effective solution.

Connecticut passed a new law last week in an effort to lower its spending on weight-loss drugs for its state insurance ...

A Wellington man is stoked to finally get his hands back on the weight loss drug he said changed his life. Wegovy was ...